tradingkey.logo
tradingkey.logo
Search

Apyx Medical Corp

APYX
Add to Watchlist
4.300USD
-0.360-7.73%
Close 07/02, 13:00ETQuotes delayed by 15 min
180.03MMarket Cap
LossP/E TTM

More Details of Apyx Medical Corp Company

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corp Info

Ticker SymbolAPYX
Company nameApyx Medical Corp
IPO dateJul 22, 1983
CEOGoodwin (Charles D)
Number of employees220
Security typeOrdinary Share
Fiscal year-endJul 22
Address5115 Ulmerton Rd
CityCLEARWATER
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33760-4004
Phone18005372790
Websitehttps://apyxmedical.com/
Ticker SymbolAPYX
IPO dateJul 22, 1983
CEOGoodwin (Charles D)

Company Executives of Apyx Medical Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.90M
+7.91%
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
16.47K
+27.13%
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.90M
+7.91%
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
493.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
16.47K
+27.13%
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

FAQs

Who are the top five shareholders of Apyx Medical Corp?

The top five shareholders of Apyx Medical Corp are: Mr. Stavros G. Vizirgianakis

How many institutions hold shares of Apyx Medical Corp (APYX)?

As of 2026Q1, 105 institutions hold shares of Apyx Medical Corp, with a combined market value of approximately 19.57M, accounting for 46.73% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1346948.00.